Evidence map›Paper›PMID 39735510›Full record

ArticleNetwork neuroscience (Cambridge, Mass.)2024

Conservation of structural brain connectivity in people with multiple sclerosis.

Gerard Martí-Juan, Jaume Sastre-Garriga, Angela Vidal-Jordana, Sara Llufriu, Eloy Martinez-Heras, Sergiu Groppa, Gabriel González-Escamilla, Maria A Rocca, Massimo Filippi, Einar A Høgestøl and 11 more

Abstract read
In one paragraph

Article in Network neuroscience (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Gerard Martí-JuanNeuroradiology Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.ORCID https://orcid.org/0000-0003-4729-7182
Jaume Sastre-GarrigaDepartment of Neurology/Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Angela Vidal-JordanaDepartment of Neurology/Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Sara LlufriuNeuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic Barcelona, Fundació de Recerca Clínic Barcelona-IDIBAPS and Universitat de Barcelona, Barcelona, Spain.
Eloy Martinez-HerasNeuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic Barcelona, Fundació de Recerca Clínic Barcelona-IDIBAPS and Universitat de Barcelona, Barcelona, Spain.
Sergiu GroppaDepartment of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), University Medical Centre of the Johannes Gutenberg University Mainz, Rhine Main Neuroscience Network (rmn2), Mainz, Germany.
Gabriel González-EscamillaDepartment of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), University Medical Centre of the Johannes Gutenberg University Mainz, Rhine Main Neuroscience Network (rmn2), Mainz, Germany.
Maria A RoccaNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Massimo FilippiNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Einar A HøgestølDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Hanne F HarboDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Michael A FosterQueen Square MS Centre, Department of Neuroinflammation, Queen Square UCL Institute of Neurology, University College London, London, United Kingdom.
Sara ColloroneQueen Square MS Centre, Department of Neuroinflammation, Queen Square UCL Institute of Neurology, University College London, London, United Kingdom.
Ahmed T ToosyQueen Square MS Centre, Department of Neuroinflammation, Queen Square UCL Institute of Neurology, University College London, London, United Kingdom.
Menno M SchoonheimAnatomy and Neurosciences, MS Centre Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Eva StrijbisNeurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Giuseppe PontilloQueen Square MS Centre, Department of Neuroinflammation, Queen Square UCL Institute of Neurology, University College London, London, United Kingdom.
Maria PetraccaDepartment of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples "Federico II", Naples, Italy.
Gustavo DecoCentre for Brain and Cognition, Computational Neuroscience Group, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain.
Àlex RoviraNeuroradiology Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Deborah ParetoNeuroradiology Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.ORCID https://orcid.org/0000-0001-7356-3769

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system. Structures affected in MS include the corpus callosum, connecting the hemispheres. Studies have shown that in mammalian brains, structural connectivity is organized according to a conservation principle, an inverse relationship between intra- and interhemispheric connectivity. The aim of this study was to replicate this conservation principle in subjects with MS and to explore how the disease interacts with it. A multicentric dataset has been analyzed including 513 people with MS and 208 healthy controls from seven different centers. Structural connectivity was quantified through various connectivity measures, and graph analysis was used to study the behavior of intra- and interhemispheric connectivity. The association between the intra- and the interhemispheric connectivity showed a similar strength for healthy controls (

Indexed as

Hemispheric connectivityMRIMultiple sclerosisStructural connectivity

Identifiers

PMID39735510
PMCPMC11674932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.